{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:27:57Z","timestamp":1794000477471,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cpcardiol.2026.103477","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:27:42Z","timestamp":1790688462000},"page":"103477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dabigatran's anti-metastatic properties for improved long-term cancer prognosis: A critical review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1666-529X","authenticated-orcid":false,"given":"Artemis","family":"Kazin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-807X","authenticated-orcid":false,"given":"Syed Imran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2026.103477_bib0001","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"The complex role of thrombin in cancer and metastasis: focus on interactions with the immune system","author":"Aleksandrowicz","year":"2024"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115027","article-title":"The role of coagulome in the tumor immune microenvironment","volume":"200","author":"Wahab","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0003","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1158\/1538-7445.AM2026-954","article-title":"Dabigatran etexilate potentiates the anti-tumor effects of anti-CTLA4 antibody through remodeling the immune microenvironment in a syngeneic mouse model of MyC-CaP cells","volume":"86","author":"Song","year":"2026","journal-title":"Cancer Res"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0004","doi-asserted-by":"crossref","unstructured":"Mani K, Deng D, Lin C, Wang M. Causes of death among people living with metastatic cancer. 2024;15(1):1519.","DOI":"10.1038\/s41467-024-45307-x"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103477_bib0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.clinthera.2012.02.022","article-title":"Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders","volume":"34","author":"Cheng","year":"2012","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103477_bib0006","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130057","article-title":"Activation of blood coagulation in cancer: implications for tumour progression","volume":"33","author":"Lima","year":"2013","journal-title":"Biosci Rep"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103477_bib0007","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4161\/cbt.10.10.13236","article-title":"Use of dabigatran etexilate to reduce breast cancer progression","volume":"10","author":"DeFeo","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103477_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2019.12.022","article-title":"A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal models","volume":"187","author":"Najidh","year":"2020","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103477_bib0009","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/biology11040596","article-title":"Commonly prescribed anticoagulants exert anticancer effects in oral squamous cell carcinoma cells in vitro","volume":"11","author":"Ling","year":"2022","journal-title":"Biology"},{"issue":"16","key":"10.1016\/j.cpcardiol.2026.103477_bib0010","doi-asserted-by":"crossref","first-page":"17184","DOI":"10.1002\/cam4.6332","article-title":"The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer","volume":"12","author":"Rees","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12957-017-1235-z","article-title":"Does antithrombotic therapy improve survival with colorectal cancer?","volume":"15","author":"Takahashi","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103477_bib0012","first-page":"1219","article-title":"Local blood coagulation drives cancer cell arrest and brain metastasis in a mouse model. Blood","volume":"137","author":"Feinauer","year":"2021","journal-title":"J Am Soc Hematol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103477_bib0013","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jth.14443","article-title":"The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice","volume":"17","author":"Buijs","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2018.02.091","article-title":"Direct oral anticoagulants do not inhibit growth and metastasis of human triple negative breast cancer in immunodeficient mice","volume":"164","author":"Buijs","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.834472","article-title":"Direct thrombin inhibitor dabigatran compromises pulmonary endothelial integrity in a murine model of breast cancer metastasis to the lungs; the role of platelets and inflammation-associated haemostasis","volume":"13","author":"Smeda","year":"2022","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103477_bib0016","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1080\/15384047.2015.1078025","article-title":"Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis","volume":"16","author":"Alexander","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2019.05.024","article-title":"Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin\/PAR-1 pathway","volume":"1719","author":"Puech","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0018","article-title":"Design and synthesis of dabigatran etexilate derivatives with inhibiting thrombin activity for hepatocellular carcinoma treatment","volume":"170","author":"Z-s","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2119\/molmed.2016.00214","article-title":"Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice","volume":"23","author":"Shi","year":"2017","journal-title":"Mol Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103477_bib0020","first-page":"877","article-title":"Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer","volume":"30","author":"Kinnunen","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103477_bib0021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ctrv.2007.02.004","article-title":"The effect of anticoagulants on cancer risk and survival: systematic review","volume":"33","author":"Tagalakis","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0022","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"Decreasing tumor growth and angiogenesis by inhibition of coagulation","author":"Nadir","year":"2019"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103477_bib0023","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0002-8703(96)90321-X","article-title":"Cancer and venous thromboembolism","volume":"132","author":"Piccioli","year":"1996","journal-title":"Am heart j"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2021.100066","article-title":"Update on the role of circulating tumour cells in cancer-associated thrombosis","volume":"5","author":"Castle","year":"2021","journal-title":"Thromb Update"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118031","article-title":"The role of thrombin in the paradoxical interplay of cancer metastasis and the vascular system: a driving dynamic","volume":"186","author":"Bayrak","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103477_bib0026","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/jth.12595","article-title":"The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials","volume":"12","author":"Sanford","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103477_bib0027","article-title":"Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation","author":"Akl","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103477_bib0028","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaoncol.2024.2503","article-title":"Aspirin use and incidence of colorectal cancer according to lifestyle risk","volume":"10","author":"Sikavi","year":"2024","journal-title":"JAMA Oncol"},{"issue":"9754","key":"10.1016\/j.cpcardiol.2026.103477_bib0029","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103477_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103477_bib0031","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.gastro.2019.06.047","article-title":"Chemoprevention of colorectal cancer","volume":"158","author":"Katona","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0032","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-med-060319-120913","article-title":"Aspirin in the prevention of colorectal neoplasia","volume":"72","author":"Drew","year":"2021","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0033","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12885-015-1634-x","article-title":"Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion","volume":"15","author":"Cooke","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103477_bib0034","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/ijc.22426","article-title":"CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models","volume":"120","author":"Ngo","year":"2007","journal-title":"Int J Cancer"},{"issue":"05","key":"10.1016\/j.cpcardiol.2026.103477_bib0035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1055\/s-0037-1615117","article-title":"Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro","volume":"79","author":"Donnelly","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2026.103477_bib0036","first-page":"1","article-title":"Hemostasis at the edge between physiology and cancer","author":"Galardi","year":"2026","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0037","first-page":"163","article-title":"Physical interactions between cancer cells and tumor microenvironment","volume":"84","author":"da","year":"2026","journal-title":"Cell Biochem Biophys"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103477_bib0038","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1074\/jbc.M704855200","article-title":"Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and \u03b21-integrin on the cell surface","volume":"283","author":"Radjabi","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/mol.114.096446","article-title":"Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro","volume":"88","author":"Chen","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"1-2","key":"10.1016\/j.cpcardiol.2026.103477_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18632\/oncotarget.211","article-title":"The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis-a possible therapeutic target","volume":"2","author":"Villares","year":"2011","journal-title":"Oncotarget"},{"issue":"63","key":"10.1016\/j.cpcardiol.2026.103477_bib0041","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21015","article-title":"Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103477_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2010.02.018","article-title":"Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation","volume":"125","author":"Borensztajn","year":"2010","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103477_bib0043","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2009.01.015","article-title":"Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation","volume":"124","author":"Borensztajn","year":"2009","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103477_bib0044","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.31557\/APJCP.2021.22.11.3601","article-title":"Efficacy of rivaroxaban use in solid tumour malignancy: Experience from a tertiary care cancer centre","volume":"22","author":"Ahmat","year":"2021","journal-title":"Asian Pacific J Cancer Prevent: APJCP"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-020-0167-1","article-title":"Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103477_bib0046","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41392-020-00366-6","article-title":"Thrombin-mediated vasculogenic mimicry: important lessons to improve anticoagulant therapy of selected cancer patients","volume":"5","author":"Spek","year":"2020","journal-title":"Signal Transduct Target Ther"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:02:35Z","timestamp":1793998955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0146280626002185"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103477","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabigatran's anti-metastatic properties for improved long-term cancer prognosis: A critical review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103477"}}